The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERON PHARMA INC | COM | 00434H108 | 1,148 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
| AEVI GENOMIC MEDICINE INC | COM | 00835P105 | 1,943 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 10,036 | 240,500 | SH | SOLE | 240,500 | 0 | 0 | ||
| ALLSCRIPTS HEALTHCARE SOLUTN | COM | 01988P108 | 2,859 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 3,182 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| AMYRIS INC | COM | 03236M101 | 2,500 | 3,425,000 | SH | SOLE | 3,425,000 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 5,090 | 82,500 | SH | SOLE | 82,500 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 6,858 | 244,500 | SH | SOLE | 244,500 | 0 | 0 | ||
| CERNER CORP | COM | 156782104 | 3,079 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 1,401 | 127,500 | SH | SOLE | 127,500 | 0 | 0 | ||
| EDITAS MEDICINE INC | COM | 28106W103 | 1,055 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| EPIZYME INC | COM | 29428V104 | 3,328 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| EVOLENT HEALTH INC | CL A | 30050B101 | 8,214 | 555,000 | SH | SOLE | 555,000 | 0 | 0 | ||
| FOUNDATION MEDICINE INC | COM | 350465100 | 9,664 | 546,000 | SH | SOLE | 546,000 | 0 | 0 | ||
| GENMARK DIAGNOSTICS INC | COM | 372309104 | 6,242 | 510,000 | SH | SOLE | 510,000 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 895 | 12,500 | SH | SOLE | 12,500 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 4,393 | 304,000 | SH | SOLE | 304,000 | 0 | 0 | ||
| ILLUMINA INC | COM | 452327109 | 3,201 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| KITE PHARMA INC | COM | 49803L109 | 4,215 | 94,000 | SH | SOLE | 94,000 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 11,561 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
| MYOKARDIA INC | COM | 62857M105 | 3,432 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 13,250 | 259,500 | SH | SOLE | 259,500 | 0 | 0 | ||
| SPARK THERAPEUTICS INC | COM | 84652J103 | 6,412 | 128,500 | SH | SOLE | 128,500 | 0 | 0 | ||
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 2,215 | 182,141 | SH | SOLE | 182,141 | 0 | 0 | ||
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | 4,905 | 385,000 | SH | SOLE | 385,000 | 0 | 0 | ||